Clorox Company (The) (NYSE:CLX) – Investment analysts at KeyCorp cut their Q2 2018 earnings per share (EPS) estimates for shares of Clorox Company (The) in a research note issued on Thursday. KeyCorp analyst J. Gere now forecasts that the company will earn $1.33 per share for the quarter, down from their prior forecast of $1.35. KeyCorp also issued estimates for Clorox Company (The)’s Q4 2018 earnings at $1.64 EPS, Q1 2019 earnings at $1.47 EPS, Q2 2019 earnings at $1.40 EPS, Q3 2019 earnings at $1.39 EPS, Q4 2019 earnings at $1.74 EPS and FY2019 earnings at $6.01 EPS.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. Clorox Company (The)’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.30 EPS.

TRADEMARK VIOLATION WARNING: This story was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/08/07/keycorp-research-analysts-decrease-earnings-estimates-for-clorox-company-the-clx.html.

CLX has been the topic of several other reports. Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. BidaskClub downgraded Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Barclays PLC dropped their target price on Clorox Company (The) from $140.00 to $136.00 and set an “equal weight” rating on the stock in a report on Friday. Finally, BMO Capital Markets set a $150.00 target price on Clorox Company (The) and gave the stock a “buy” rating in a report on Thursday. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $129.13.

Shares of Clorox Company (NYSE:CLX) opened at 134.49 on Monday. The company has a 50-day moving average price of $134.79 and a 200-day moving average price of $133.07. The stock has a market capitalization of $17.32 billion, a price-to-earnings ratio of 26.57 and a beta of 0.40. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76.

Hedge funds and other institutional investors have recently bought and sold shares of the company. American Beacon Advisors Inc. acquired a new position in Clorox Company (The) during the first quarter valued at $104,000. Quadrant Capital Group LLC boosted its position in Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. boosted its position in Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares in the last quarter. Finally, Blue Chip Partners Inc. boosted its position in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares in the last quarter. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Earnings History and Estimates for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.